Treatment of Alzheimer's disease.
Bowen
D M
DM
Francis
P T
PT
Procter
A W
AW
Young
A B
AB
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000503:physiopathology; D002540:Cerebral Cortex / Q000187:drug effects* / Q000503:physiopathology; D003523:Cycloserine / Q000627:therapeutic use*; D006801:Humans; D009483:Neuropsychological Tests; D018009:Receptors, Glycine; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects* / Q000502:physiology; D017981:Receptors, Neurotransmitter / Q000187:drug effects* / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects* / Q000502:physiology
D018009:Receptors, Glycine; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter; D003523:Cycloserine